131 related articles for article (PubMed ID: 22528800)
21. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases.
Goedert M; Cuenda A; Craxton M; Jakes R; Cohen P
EMBO J; 1997 Jun; 16(12):3563-71. PubMed ID: 9218798
[TBL] [Abstract][Full Text] [Related]
22. Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy.
Liu J; Han X; Zhang T; Tian K; Li Z; Luo F
J Hematol Oncol; 2023 Nov; 16(1):116. PubMed ID: 38037103
[TBL] [Abstract][Full Text] [Related]
23. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.
Kitzberger C; Shehzad K; Morath V; Spellerberg R; Ranke J; Steiger K; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
Mol Ther Oncolytics; 2023 Sep; 30():238-253. PubMed ID: 37701849
[TBL] [Abstract][Full Text] [Related]
25. LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma.
Douglas C; Lomeli N; Vu T; Pham J; Bota DA
bioRxiv; 2023 Apr; ():. PubMed ID: 37131765
[TBL] [Abstract][Full Text] [Related]
26. Fluoride in the Central Nervous System and Its Potential Influence on the Development and Invasiveness of Brain Tumours-A Research Hypothesis.
Żwierełło W; Maruszewska A; Skórka-Majewicz M; Gutowska I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675073
[TBL] [Abstract][Full Text] [Related]
27. The functional role of p38 MAPK pathway in malignant brain tumors.
Grave N; Scheffel TB; Cruz FF; Rockenbach L; Goettert MI; Laufer S; Morrone FB
Front Pharmacol; 2022; 13():975197. PubMed ID: 36299892
[TBL] [Abstract][Full Text] [Related]
28. Dimethyl Fumarate Ameliorates Paclitaxel-Induced Neuropathic Pain in Rats.
Singh J; Thapliyal S; Kumar A; Paul P; Kumar N; Bisht M; Naithani M; Rao S; Handu SS
Cureus; 2022 Sep; 14(9):e28818. PubMed ID: 36225395
[TBL] [Abstract][Full Text] [Related]
29. Converging Mechanisms of Epileptogenesis and Their Insight in Glioblastoma.
Hills KE; Kostarelos K; Wykes RC
Front Mol Neurosci; 2022; 15():903115. PubMed ID: 35832394
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of Glioblastoma Multiforme-Literature Review.
Grochans S; Cybulska AM; Simińska D; Korbecki J; Kojder K; Chlubek D; Baranowska-Bosiacka I
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626018
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic Underpinnings of Inflammation: A Key to Unlock the Tumor Microenvironment in Glioblastoma.
Chen N; Peng C; Li D
Front Immunol; 2022; 13():869307. PubMed ID: 35572545
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy of glioblastoma: Recent advances and future prospects.
Yuan B; Wang G; Tang X; Tong A; Zhou L
Hum Vaccin Immunother; 2022 Nov; 18(5):2055417. PubMed ID: 35344682
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance.
Wang QW; Lin WW; Zhu YJ
Cell Commun Signal; 2022 Jan; 20(1):6. PubMed ID: 35000592
[TBL] [Abstract][Full Text] [Related]
34. Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications.
Basheer AS; Abas F; Othman I; Naidu R
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439380
[TBL] [Abstract][Full Text] [Related]
35. BIRB796, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells.
Zhao L; Wang Y; Xu Y; Sun Q; Liu H; Chen Q; Liu B
ACS Omega; 2021 May; 6(17):11466-11473. PubMed ID: 34056302
[TBL] [Abstract][Full Text] [Related]
36. IL-1
Dai J; Shen J; Chai Y; Chen H
Mediators Inflamm; 2021; 2021():6645766. PubMed ID: 34054346
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies.
D'Orazi G; Cordani M; Cirone M
Cell Mol Life Sci; 2021 Mar; 78(5):1853-1860. PubMed ID: 33070220
[TBL] [Abstract][Full Text] [Related]
38. In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.
Ariey-Bonnet J; Carrasco K; Le Grand M; Hoffer L; Betzi S; Feracci M; Tsvetkov P; Devred F; Collette Y; Morelli X; Ballester P; Pasquier E
Mol Oncol; 2020 Dec; 14(12):3083-3099. PubMed ID: 33021050
[TBL] [Abstract][Full Text] [Related]
39. Minocycline in Treating Glioblastoma Multiforme: Far beyond a Conventional Antibiotic.
Afshari AR; Mollazadeh H; Sahebkar A
J Oncol; 2020; 2020():8659802. PubMed ID: 33014057
[TBL] [Abstract][Full Text] [Related]
40. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
Front Immunol; 2020; 11():1402. PubMed ID: 32765498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
